Advertisement

Topics

Vacsera Biological Products & Vaccines Holding Company Company Profile

14:27 EDT 28th May 2017 | BioPortfolio

On behalf of all of our staff members, we welcome you to our Web site. Here you will learn more about our corporate vision , values , goals ,products
and services as well as our affiliated companies.

Vacsera is the leading company in the field of biological products &vaccines
manufacturing in Egypt and the Middle East.

We are focused on pursuing strategic investment opportunities in a number
of sectors within the pharmaceutical and biopharmaceutical industries.

These include research and development, manufacturing, distribution, and intellectual property acquisitions.

Location

51 Wizaret El-Zeraa - Agouza
Giza
22311
Egypt

Contact

Phone: (202) 76 111 11
Fax: (202) 33 698 72
Email: ceo@vacsera.com


News Articles [4167 Associated News Articles listed on BioPortfolio]

Express Scripts Holding Company Strategy, SWOT and Corporate Finance Report Prices from USD $175

SummaryExpress Scripts Holding Company Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW...

Deals this week: Shenzhen Kangtai Biological Products, Telix Pharmaceuticals, Fresenius Finance Ireland

Chinese vaccine and biologic products developer and manufacturer Shenzhen Kangtai Biological Products has announced the pricing for an initial public offering (IPO) of shares to raise ¥138.2m ($20.08...

Boehringer Ingelheim to Sell Off Animal Health Products to Lilly, Bayer

Boehringer Ingelheim will sell five of its animal health products in the U.S. to settle a complaint by the Federal Trade Commission (FTC) that its planned swap of businesses with Sanofi would be antic...

Middle East and Africa Veterinary Vaccines Market Segmented By Animal Type, Technology and By Country Industry Analysis, Market Size, Extensive Company Shares, Growth Trends and YOY Forecasts 20162021 [Updated: 01012017] Prices from USD $2875

The MiddleEast Africa animal vaccines market is poised to reach $541.4 Million by 2021 from $389.6 Million in 2016, at a CAGR of 6.8% from 2016 to 2021. Veterinary Vaccines are important and, at tim...

China Biologic Products to Report First Quarter of 2017 Financial Results

BEIJING, China, April 21, 2017 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company ...

FDA Releases Final Guidance for 'Nonproprietary Naming of Biological Products'

NewsThe guidance describes FDA's current thinking on the need for biological products licensed under the Public Health Service Act to bear nonproprietary names that include an FDA-designated suffix.

ASBM Release: Company Statement On Final Guidance For Industry Nonproprietary Naming Of Biological Products

  Life Sciences Jobs   ...

Broad Patent Granted for ENABL® Adjuvant Technology

ST. JOSEPH, Mo., May 9, 2017 /PRNewswire/ -- AgriLabs® has received a U.S. patent for ENABL® adjuvant technology and its use as a delivery system for DNA vaccines in development. The patent cov...

PubMed Articles [2763 Associated PubMed Articles listed on BioPortfolio]

DNA Vaccines: Regulatory Considerations and Safety Aspects.

DNA vaccines have great potential as preventive or therapeutic vaccines against viral, bacterial, or parasitic diseases as well as cancer, and may also be used as gene therapy products. Although many ...

Rapid immunization effects of a new type of 60μg hepatitis B vaccine compared with traditional 20μg hepatitis B vaccines in adults.

The widely recommended standard schedule of hepatitis B vaccine for adults is months 0, 1 and 6, which takes 6 months to complete. Rapid completion of one vaccination schedule is important to adults ...

Lyophilization of Adjuvanted Vaccines: Methods for Formulation of a Thermostable Freeze-Dried Product.

Lyophilization of vaccines is advantageous for the distribution and storage of thermally labile products, particularly in regions where cold chain management is difficult. To date, current lyophilized...

The European Regulatory Environment of RNA-Based Vaccines.

A variety of different mRNA-based drugs are currently in development. This became possible, since major breakthroughs in RNA research during the last decades allowed impressive improvements of transla...

Fluorescent natural products as probes and tracers in biology.

Covering: 1985 up to the end of 2016Fluorescence is a remarkable property of many natural products in addition to their medicinal and biological values. Herein, we provide a review on these peculiar s...

Clinical Trials [2885 Associated Clinical Trials listed on BioPortfolio]

Energy Cost for Holding a MedGem® Indirect Calorimeter

The goal of this clinical protocol is to perform a randomized crossover study to determine the energy cost of holding the MedGem® device above a person's normal resting metabolic rate (RM...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Kangaroo Holding Effects on Breast Milk

Kangaroo holding is a skin-to-skin method of holding a baby. Many research studies have investigated the maternal and infant benefits associated with kangaroo holding. The purpose of thi...

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

The purpose of this study is to compare two measles, mumps and rubella conjugate vaccines (manufactured by GSK and Merck and Company ) in terms of the immune response elicited and safety w...

Kangaroo Holding and Maternal Stress

The primary objective is to determine if kangaroo holding in the first week after birth influences the stress levels of mothers who have delivered their infants prematurely and who require...

Companies [3771 Associated Companies listed on BioPortfolio]

Vacsera Biological Products & Vaccines Holding Company

On behalf of all of our staff members, we welcome you to our Web site. Here you will learn more about our corporate vision , values , goals ,productsand services as well as our affiliated companies.Va...

ASCIInc

ASCIInc is a premiere Healthcare and Life Science Company that understands the labyrinth of possibilities involving immunization and vaccination programs utilizes an intelligent eidetic system includi...

Biological E Limited

Humanity has come a long way. With gradual effort, today we are in a position to prevent major life-threatening illnesses. However the quest for healthy life is an ever-lasting journey. Biological E. ...

Embrex Incorporated

Embrex, Inc. develops and markets biological delivery technology and biological products to increase the productivity andprofitability of the global poultry industry. Embrex has developed and commerci...

Avant Immunotherapeutics

AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. The company is developing a...

More Information about "Vacsera Biological Products & Vaccines Holding Company" on BioPortfolio

We have published hundreds of Vacsera Biological Products & Vaccines Holding Company news stories on BioPortfolio along with dozens of Vacsera Biological Products & Vaccines Holding Company Clinical Trials and PubMed Articles about Vacsera Biological Products & Vaccines Holding Company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vacsera Biological Products & Vaccines Holding Company Companies in our database. You can also find out about relevant Vacsera Biological Products & Vaccines Holding Company Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record